drugset / Trial / NCT01572454
Comparison of Dexmedetomidine and Remifentanil Infusion During CABG
RandomizedParallel-groupSingle-blind
Summary
We are trying to investigate whether intraoperative dexmedetomidine infusion could decrease the incidence of intraoperative hypokalemia and arrhythmia, and myocardial injury in patients undergoing off-pump coronary artery bypass graft, and trying compare these effects with those of remifentanil infusion.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.3 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 0.7 ug/kg | — |
| Comparator | Remifentanil | Small molecule | 0.05 ug/kg | — |
| Comparator | Remifentanil | Small molecule | 0.3 ug/kg | — |